Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 16:35
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 714°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
¡°ÃÊ°íÀ§Ç豺 LDL-C ¸ñǥġ ÇÏÇâ±¹¸é ¶Ñ·Ç¡±
ÀÌ»óµ· ±âÀÚ
2023-03-10 18:33
[Sub Story]
½ºÅ¸Æ¾°ú ÇÔ²² ÇÑ LDL-C ¸ñǥġ º¯Ãµ»ç
ÀÌ»óµ· ±âÀÚ
2023-03-10 18:04
[Sub Story]
IMPROVE-IT, ºñ½ºÅ¸Æ¾°è ¹«¿ë·Ð ÀáÀç¿ö
ÀÌ»óµ· ±âÀÚ
2023-03-10 17:48
[Sub Story]
¡°ÀþÀº ¼ºÀÎ °íÇ÷¾Ð ȯÀÚ ÀÎÁöµµ, ¿©ÀüÇÑ °úÁ¦¡±
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 17:35
[Sub Story]
RAS¾ïÁ¦Á¦¡¤CCB¡¤ÀÌ´¢Á¦ Áß º´¿ëÁ¶ÇÕÀº?
ÀÌ»óµ· ±âÀÚ
2023-03-10 17:13
¶óÀÎ
[Sub Story]
º´¿ë½Ã±â »¡¶óÁöÀÚ SPC ºÎ°¢
ÀÌ»óµ· ±âÀÚ
2023-03-10 16:38
[Sub Story]
Çѱ¹ÀÎ Ç÷´ç°ÇÏÁ¦ ó¹æ µ¹¾Æº¸´Ï¡¦
ÀÌ»óµ· ±âÀÚ
2023-03-10 16:08
[Sub Story]
¸ñÇ¥Ç÷´ç, ȯÀÚ µû¶ó °³º°È¿¡ ¹æÁ¡
ÀÌ»óµ· ±âÀÚ
2023-03-10 16:03
[Sub Story]
Ç÷´ç°ÇÏÁ¦ ÀûÀÀÁõ µµÀü °è¼ÓµÈ´Ù
ÀÌ»óµ· ±âÀÚ
2023-03-10 15:09
[Sub Story]
¡°GLP-1RA ±â¹Ý Ä¡·áÁ¦ ¾àÁø °è¼ÓµÉ °Í¡±
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 14:37
¶óÀÎ
[Sub Story]
¼¼¸¶±Û·çŸÀ̵塤¸®¶ó±Û·çŸÀ̵å ÁÖ¿ä Àü·«À¸·Î ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 14:12
[Sub Story]
GLP-1RA¡¤Àν¶¸° Ç÷´çÁ¶Àý °µµ ¡®³ôÀ½¿¡¼ ¸Å¿ì ³ôÀ½¡¯
ÀÌ»óµ· ±âÀÚ
2023-02-07 11:10
[Sub Story]
Ä¡·á¸ñÇ¥, µÎ°¥·¡·Î ³ª´¶´Ù
ÀÌ»óµ· ±âÀÚ
2023-02-07 11:01
[Sub Story]
¡°¸ÞÆ®Æ÷¸£¹Î, ½ÉÇ÷°üÁúȯ À§Çè°¨¼Ò ÇýÅà °¡´É¡±
ÀÌ»óµ· ±âÀÚ
2023-02-07 10:46
[Sub Story]
Ç÷´ç¡¤Ç÷¾Ð¡¤ÁöÁúÁ¶Àý ¸ñÀûÀº ½ÉÇ÷°üÁúȯ ¿¹¹æ
ÀÌ»óµ· ±âÀÚ
2023-02-07 10:36
¶óÀÎ
[Sub Story]
Ç÷´çÀÌ»ó µ¿¹Ý Áö¹æ°£ 20~30´ë¿¡¼ °¡Àå ³ô¾Æ
ÀÓ¼¼Çü ±âÀÚ
2023-02-07 10:13
[Sub Story]
¼ºÀÎ °ñ´Ù°øÁõ¿¡ ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ® 1Â÷·Î ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2023-02-06 18:47
[Sub Story]
GERD °Ë»ç°á°ú¿¡ µû¸¥ ¸ÂÃãÇü Ä¡·áÀü·« Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 19:15
[Sub Story]
ȯÀÚ Áúȯº°¡¤¿ª·ù¼º ½Äµµ¿° ÁßÁõµµº° ¾Ë°í¸®µë Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 19:12
[Sub Story]
GERD °ü¸®¿¡¼ ±»°ÇÇÑ PPI ÀÔÁö È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 18:38
-
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top